Document is current
Any future updates will be listed below
-
Authors
Tan, Darrell H. S. https://orcid.org/0000-0002-3069-2875
Agrawal, Rupesh
Barnabas, Ruanne V.
Giles, Jon T.
Dull, Peter
-
Funding
Funding for this research was provided by:
Canada Research Chairs
- License Information
-
More Information
Article History
Received: 12 August 2020
Accepted: 19 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: Dr. Tan reports grants from the Canada Research Chairs Program during the conduct of the work, grants from Gilead, grants from Viiv Healthcare, grants from Abbvie, and other (participation as a Site PI in industry-sponsored clinical trials) from Glaxo SmithKline, outside the submitted work. Dr. Giles reports personal fees from Eli Lilly, personal fees from Gilead, personal fees from AbbVie, personal fees from Bristol Meyers Squibb, and personal fees from UCB, grants from Pfizer, outside the submitted work. Drs. Agrawal, Barnabas, and Dull have nothing to disclose.
